144 related articles for article (PubMed ID: 20873795)
1. Carbocycles related to oseltamivir as influenza virus group-1-specific neuraminidase inhibitors. Binding to N1 enzymes in the context of virus-like particles.
Mohan S; McAtamney S; Haselhorst T; von Itzstein M; Pinto BM
J Med Chem; 2010 Oct; 53(20):7377-91. PubMed ID: 20873795
[TBL] [Abstract][Full Text] [Related]
2. Exploitation of the catalytic site and 150 cavity for design of influenza A neuraminidase inhibitors.
Adabala PJ; LeGresley EB; Bance N; Niikura M; Pinto BM
J Org Chem; 2013 Nov; 78(21):10867-77. PubMed ID: 24090215
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and in vitro study of novel neuraminidase inhibitors against avian influenza virus.
Kongkamnerd J; Cappelletti L; Prandi A; Seneci P; Rungrotmongkol T; Jongaroonngamsang N; Rojsitthisak P; Frecer V; Milani A; Cattoli G; Terregino C; Capua I; Beneduce L; Gallotta A; Pengo P; Fassina G; Miertus S; De-Eknamkul W
Bioorg Med Chem; 2012 Mar; 20(6):2152-7. PubMed ID: 22342267
[TBL] [Abstract][Full Text] [Related]
4. Inhibitor selectivity of a new class of oseltamivir analogs against viral neuraminidase over human neuraminidase enzymes.
Albohy A; Mohan S; Zheng RB; Pinto BM; Cairo CW
Bioorg Med Chem; 2011 May; 19(9):2817-22. PubMed ID: 21489803
[TBL] [Abstract][Full Text] [Related]
5. Replication inhibition activity of carbocycles related to oseltamivir on influenza A virus in vitro.
Niikura M; Bance N; Mohan S; Mario Pinto B
Antiviral Res; 2011 Jun; 90(3):160-3. PubMed ID: 21443905
[TBL] [Abstract][Full Text] [Related]
6. Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus.
Du QS; Wang SQ; Chou KC
Biochem Biophys Res Commun; 2007 Oct; 362(2):525-31. PubMed ID: 17707775
[TBL] [Abstract][Full Text] [Related]
7. On the structure-based design of novel inhibitors of H5N1 influenza A virus neuraminidase (NA).
Mitrasinovic PM
Biophys Chem; 2009 Mar; 140(1-3):35-8. PubMed ID: 19117662
[TBL] [Abstract][Full Text] [Related]
8. Discovery of N-substituted oseltamivir derivatives as potent and selective inhibitors of H5N1 influenza neuraminidase.
Xie Y; Xu D; Huang B; Ma X; Qi W; Shi F; Liu X; Zhang Y; Xu W
J Med Chem; 2014 Oct; 57(20):8445-58. PubMed ID: 25255388
[TBL] [Abstract][Full Text] [Related]
9. Design of oseltamivir analogs inhibiting neuraminidase of avian influenza virus H5N1.
Rungrotmongkol T; Frecer V; De-Eknamkul W; Hannongbua S; Miertus S
Antiviral Res; 2009 Apr; 82(1):51-8. PubMed ID: 19428595
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of viral group-1 and group-2 neuraminidases by oseltamivir: A comparative structural analysis by the ScrewFit algorithm.
Calligari PA; Kneller GR; Giansanti A; Ascenzi P; Porrello A; Bocedi A
Biophys Chem; 2009 Apr; 141(1):117-23. PubMed ID: 19195766
[TBL] [Abstract][Full Text] [Related]
11. Source of oseltamivir resistance in avian influenza H5N1 virus with the H274Y mutation.
Malaisree M; Rungrotmongkol T; Nunthaboot N; Aruksakunwong O; Intharathep P; Decha P; Sompornpisut P; Hannongbua S
Amino Acids; 2009 Oct; 37(4):725-32. PubMed ID: 19002747
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of tamiflu and its phosphonate congeners possessing potent anti-influenza activity.
Shie JJ; Fang JM; Wang SY; Tsai KC; Cheng YS; Yang AS; Hsiao SC; Su CY; Wong CH
J Am Chem Soc; 2007 Oct; 129(39):11892-3. PubMed ID: 17850083
[No Abstract] [Full Text] [Related]
13. Computational design of novel, high-affinity neuraminidase inhibitors for H5N1 avian influenza virus.
Park JW; Jo WH
Eur J Med Chem; 2010 Feb; 45(2):536-41. PubMed ID: 19914748
[TBL] [Abstract][Full Text] [Related]
14. Biotin-, fluorescein- and 'clickable' conjugates of phospha-oseltamivir as probes for the influenza virus which utilize selective binding to the neuraminidase.
Stanley M; Martin SR; Birge M; Carbain B; Streicher H
Org Biomol Chem; 2011 Aug; 9(16):5625-9. PubMed ID: 21720632
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluation of "Multi-Site"-binding influenza virus neuraminidase inhibitors.
Jia R; Zhang J; Ai W; Ding X; Desta S; Sun L; Sun Z; Ma X; Li Z; Wang D; Huang B; Zhan P; Liu X
Eur J Med Chem; 2019 Sep; 178():64-80. PubMed ID: 31176096
[TBL] [Abstract][Full Text] [Related]
16. Correlation analyses on binding affinity of sialic acid analogues with influenza virus neuraminidase-1 using ab initio MO calculations on their complex structures.
Hitaoka S; Harada M; Yoshida T; Chuman H
J Chem Inf Model; 2010 Oct; 50(10):1796-805. PubMed ID: 20863103
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationship studies of novel carbocyclic influenza neuraminidase inhibitors.
Kim CU; Lew W; Williams MA; Wu H; Zhang L; Chen X; Escarpe PA; Mendel DB; Laver WG; Stevens RC
J Med Chem; 1998 Jul; 41(14):2451-60. PubMed ID: 9651151
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological activity of thiazolidine-4-carboxylic acid derivatives as novel influenza neuraminidase inhibitors.
Liu Y; Jing F; Xu Y; Xie Y; Shi F; Fang H; Li M; Xu W
Bioorg Med Chem; 2011 Apr; 19(7):2342-8. PubMed ID: 21382719
[TBL] [Abstract][Full Text] [Related]
19. Virtual screening pipeline and ligand modelling for H5N1 neuraminidase.
D'Ursi P; Chiappori F; Merelli I; Cozzi P; Rovida E; Milanesi L
Biochem Biophys Res Commun; 2009 Jun; 383(4):445-9. PubMed ID: 19371724
[TBL] [Abstract][Full Text] [Related]
20. Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 2. Crystallographic and molecular modeling study of complexes of 4-amino-4H-pyran-6-carboxamides and sialidase from influenza virus types A and B.
Taylor NR; Cleasby A; Singh O; Skarzynski T; Wonacott AJ; Smith PW; Sollis SL; Howes PD; Cherry PC; Bethell R; Colman P; Varghese J
J Med Chem; 1998 Mar; 41(6):798-807. PubMed ID: 9526556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
